+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Levorphanol 2018 U.S. Promotional Audit Report

  • ID: 4615841
  • Report
  • Region: United States
  • 28 pages
  • MD Details
1 of 3

FEATURED COMPANIES

The 5 Key Questions Addressed by this Report:
  • How many physicians were reached by Levorphanol through reportable promotional activity in 2018 and how does this compare to its peer set in the Pain - Opioids market?
  • What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend for each type of activity?
  • How does Sentynl's depth of coverage vary within key specialties (e.g., Anesthesiology, Pain Medicine, Physical Medicine and Rehabilitation, Neurology, Family Medicine, and Internal Medicine) and how does this compare to its peers and the overall set of rep-accessible physicians?
  • How often are physicians receiving paid meals for Levorphanol throughout the year (e.g., monthly, quarterly, annually)?
  • Who were the most frequent meal recipients and top paid speakers for Levorphanol in 2018?
Data Sources and Methodology:
  • Author leverages company-reported financial transaction data disclosed through CMS Open Payments. This data set captures all transfers of value (e.g., speaking fees, consulting fees, travel, education, and meals) made on behalf of a drug or device manufacturer to a physician. Currently, over 5 years of longitudinal data is available - covering payments to more than 1,000,000 U.S. healthcare professionals.
  • Over 3,900 paid interactions across 1,300 physicians made on behalf of Levorphanol were carefully examined to support our analysis. In addition, interaction data from 11 peer products (i.e. Arymo ER, Belbuca, Embeda, Hysingla ER, Morphabond ER, Nucynta, Oxaydo, OxyContin, Subsys, Xtampza ER, and Zohydro ER) was leveraged to provide benchmarking and market insights.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

Overview:
  • Introduction
  • Sunshine Act and Open Payments Data
  • Transfer of Value
  • Author's Platform
Levorphanol - Peer Set:
  • Levorphanol Peer Set Selection
Levorphanol - Promotional Benchmarking:
  • Chart 1 Total Number of Physicians Reached by Specialty Type
  • Chart 2 Distribution of Physicians Reached by Specialty Type
  • Chart 3 Total Number of Payments by Type
  • Chart 4 Distribution of Payments by Type
  • Chart 5 Total Number of Payments / Week
  • Chart 6 Payment Value by Type
Levorphanol - Physician Coverage by Geography:
  • Chart 7 Anesthesiology
  • Chart 8 Pain Medicine
  • Chart 9 Physical Medicine and Rehabilitation
  • Chart 10 Neurology
  • Chart 11 Family Medicine
  • Chart 12 Internal Medicine
Levorphanol - Meal Frequency:
  • Chart 13 Anesthesiology
  • Chart 14 Pain Medicine
  • Chart 15 Physical Medicine and Rehabilitation
  • Chart 16 Neurology
  • Chart 17 Family Medicine
  • Chart 18 Internal Medicine
Levorphanol - Most Engaged Physicians:
  • Table 1: Top Physicians (By Total Number of Meals) in 2018
  • Table 2: Top Speakers (By Total Number of Speaking Events) in 2018
About:
  • Background
  • Service Lines
  • Contact
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Sentynl
Note: Product cover images may vary from those shown
Adroll
adroll